ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

NeuroStim TMS Surpasses 250,000 Treatments, Expands into Minnesota with new Bloomington Clinic

(PRUnderground) October 14th, 2025

NeuroStim TMS, a leading national provider of Transcranial Magnetic Stimulation (TMS) Therapy, is proud to announce a major milestone: 250,000 TMS Treatments delivered. This achievement comes as the company expands into the state of Minnesota with the opening of its new clinic in Bloomington and plans to open a second location in Minneapolis in November.

Founded in 2018, NeuroStim TMS provides FDA-approved, non-invasive TMS Therapy to patients living with Treatment-Resistant Depression, OCD, Anxiety, and other conditions. With clinics established across the Pacific Northwest and Arizona, NeuroStim has become a trusted leader in advanced mental health care. The expansion into Minnesota represents NeuroStim’s first footprint in the Midwest, extending access to a rapidly growing and highly effective alternative treatment for individuals across the Twin Cities region.

“Our expansion into Minnesota is about more than growth, it’s about meeting a clear need for advanced, effective, and compassionate mental health care in the Twin Cities,” said Walt Guidice, CEO of NeuroStim TMS. “Reaching 250,000 treatments is an incredible milestone, but the true impact is seen in the lives transformed by TMS Therapy. We’re honored to bring this proven treatment option to Bloomington and Minneapolis.” 

About TMS Therapy 

TMS Therapy is a safe, drug-free, non-invasive treatment approved by the FDA for Major Depressive Disorder (MDD), OCD, Anxious Depression and other mood disorders. It is recognized by the American Psychiatric Association in its Best Practices Guidelines as an effective treatment for major depression. Unlike traditional medications, TMS is free of drug-related side effects and is especially effective for individuals who have not found relief through antidepressants or talk therapy. Clinical results at NeuroStim TMS show 71.5% of patients achieving at least 50% improvement in symptoms, with 46% reaching full remission. These results underscore the growing recognition of TMS Therapy as a reliable and durable treatment for treatment-resistant mental health conditions.

Expanding Access to Mental Health Care in Minnesota 

NeuroStim’s new Bloomington clinic is poised to play a critical role in supporting the mental wellness of individuals across the region. The upcoming Minneapolis location will further expand NeuroStim’s ability to serve patients across the Twin Cities at a time when Minnesota has faced growing demand for innovative mental health solutions.

About NeuroStim TMS 

NeuroStim TMS is a leading national provider of TMS Therapy and TMS research center, with sixteen (16) clinics across Washington, Arizona, and now Minnesota. Led by a team of nationally recognized TMS experts, NeuroStim offers evidence-based, non-invasive treatments for depression and other mood disorders, helping patients who have not responded to traditional options. NeuroStim is the proud pioneer of the One-Day TMS™ protocol and a premier provider of accelerated TMS in the U.S. The company is committed to advancing excellence in mental health care through innovation, clinical expertise, and compassionate treatment.

For more information about NeuroStim TMS and its services, visit www.neurostimtms.com.

To schedule an appointment at the new Bloomington location, please contact:
Bloomington@NeuroStimTMS.com

For media inquiries:
Hello@NeuroStimTMS.com

About NeuroStim TMS Bloomington

NeuroStim TMS Bloomington is located in the Minnesota Center at 7760 France Avenue, Suite 920, Bloomington, MN 55435. Dr. Amit Mohan, a nationally recognized TMS expert and former Mayo Clinic physician, serves as lead provider and Medical Director. NeuroStim TMS Bloomington is a division of NeuroStim TMS Centers, a leading national provider of Transcranial Magnetic Stimulation (TMS) Therapy. Our experienced providers collaborate with mental health professionals, referring physicians, and their patients to deliver advanced, evidence-based TMS Therapy for Major Depressive Disorder, Postpartum Depression, Anxiety disorders including OCD, PTSD, and Generalized Anxiety Disorder in Minnesota. NeuroStim TMS is passionately committed to setting the standard for excellence in mental health care by providing advanced treatments and compassionate, personalized care.

The post NeuroStim TMS Surpasses 250,000 Treatments, Expands into Minnesota with new Bloomington Clinic first appeared on

Press Contact

Name: Media Inquiries
Phone: (888)-995-6458
Email: Contact Us

Original Press Release.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  216.48
+0.00 (0.00%)
AAPL  262.24
+0.00 (0.00%)
AMD  240.56
+0.00 (0.00%)
BAC  52.04
+0.00 (0.00%)
GOOG  257.02
+0.00 (0.00%)
META  732.17
+0.00 (0.00%)
MSFT  516.79
+0.00 (0.00%)
NVDA  182.64
+0.00 (0.00%)
ORCL  277.18
+0.00 (0.00%)
TSLA  447.43
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.